Roche secures CE mark for ovarian cancer detection test

By Yahoo! Finance   |   1 year ago
Roche secures CE mark for ovarian cancer detection test

Roche's VENTANA FOLR1 RxDx Assay has received CE mark approval for identifying epithelial ovarian cancer patients suitable for AbbVie's ELAHERE therapy.

Read More

Did you find this insightful?